AcquisitionOther
Lantheus Holdings, Inc. acquired Life Molecular Imaging
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Lantheus Holdings, Inc. -> Life Molecular Imaging · $350 million
The acquisition is expected to immediately enhance Lantheus near and long-term growth profile and establish a commercial Alzheimers disease (AD) franchise with the addition of Neuraceq ® (florbetaben F18 injection).
Open source record (SEC) ↗